[HTML][HTML] Potential herb–drug interactions between anti-COVID-19 drugs and traditional Chinese medicine

L Ye, S Fan, P Zhao, C Wu, M Liu, S Hu, P Wang… - … Pharmaceutica Sinica B, 2023 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has spread worldwide. Effective treatments against …

Systemic inflammation index, disease severity, and mortality in patients with COVID-19: A systematic review and meta-analysis

AA Mangoni, A Zinellu - Frontiers in Immunology, 2023 - frontiersin.org
Introduction An excessive systemic pro-inflammatory state increases the risk of severe
disease and mortality in patients with coronavirus disease 2019 (COVID-19). However, there …

Microvascular thrombosis as a critical factor in severe COVID-19

PP Wadowski, B Panzer, A Józkowicz… - International Journal of …, 2023 - mdpi.com
Platelet–endothelial interactions have a critical role in microcirculatory function, which
maintains tissue homeostasis. The subtle equilibrium between platelets and the vessel wall …

Mechanisms of COVID-19 associated pulmonary thrombosis: a narrative review

CM Niculae, A Hristea, R Moroti - Biomedicines, 2023 - mdpi.com
COVID-19, the infectious disease caused by severe acute respiratory syndrome coronavirus-
2 (SARS-CoV-2), is frequently associated with pulmonary thrombotic events, especially in …

[HTML][HTML] Aggregate index of systemic inflammation (AISI), disease severity, and mortality in COVID-19: a systematic review and meta-analysis

A Zinellu, P Paliogiannis, AA Mangoni - Journal of Clinical Medicine, 2023 - mdpi.com
Combined indices of different haematological cell types appear to be particularly promising
for investigating the link between systemic inflammation and coronavirus disease 2019 …

Biomarkers of oxidative stress and inflammation in subjects with COVID-19: Characterization and prognosis of the disease

PMV Coronel, IC Pereira, DCLS Basilio… - Microbial …, 2023 - Elsevier
Abstract Coronavirus disease (COVID-19) is an acute respiratory disease caused by the
new coronavirus (SARS-CoV-2) that has spread throughout the world causing millions of …

A comprehensive IDA and SWATH-DIA Lipidomics and Metabolomics dataset: SARS-CoV-2 case control study

A Tahir, A Draxler, T Stelzer, A Blaschke, B Laky… - Scientific Data, 2024 - nature.com
A significant hurdle in untargeted lipid/metabolomics research lies in the absence of reliable,
cross-validated spectral libraries, leading to a considerable portion of LC-MS features being …

Impairment of platelet function in both mild and severe COVID‐19 patients

M Scavone, C Ghali, M Calogiuri, M Sala… - British Journal of …, 2023 - Wiley Online Library
Abnormalities of platelet function were reported in patients with severe COVID‐19 (severe‐
C), but few data are available in patients with mild COVID‐19 (mild‐C) and after COVID‐19 …

[HTML][HTML] Impaired fibrinolytic potential predicts oxygen requirement in COVID-19

J Wang, KW Choy, HY Lim, P Ho - Journal of Personalized Medicine, 2022 - mdpi.com
Abnormal coagulation and fibrinolysis contributes to the respiratory distress syndrome in
COVID-19. We aimed to explore the association of impaired fibrinolytic potential with …

[HTML][HTML] A Comparison of the Clinical and Epidemiological Profile of Rocky Mountain Spotted Fever with Dengue and COVID-19 in Hospitalized Children, Sonora …

G Álvarez-Hernández, CN Rivera-Rosas… - Tropical Medicine and …, 2025 - mdpi.com
Background: Rocky Mountain spotted fever (RMSF) is a challenge for physicians because
the disease can mimic other endemic febrile illnesses, such as dengue and COVID-19. The …